PRUDENTIAL FINANCIAL INC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 193 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2018. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRUDENTIAL FINANCIAL INC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$3,783,374
-51.4%
75,336
-38.9%
0.01%
-45.5%
Q2 2023$7,787,694
+3379.4%
123,223
+2376.8%
0.01%
Q1 2023$223,825
+2.1%
4,975
-0.6%
0.00%
Q4 2022$219,181
-33.4%
5,003
-0.0%
0.00%
-100.0%
Q3 2022$329,000
-2.9%
5,005
-22.8%
0.00%0.0%
Q2 2022$339,000
-91.6%
6,484
-89.8%
0.00%
-80.0%
Q1 2022$4,059,000
-66.0%
63,538
-42.6%
0.01%
-66.7%
Q4 2021$11,933,000
+7.5%
110,664
+2.5%
0.02%0.0%
Q3 2021$11,101,000
-6.3%
107,958
-19.9%
0.02%
-6.2%
Q2 2021$11,853,000
-36.3%
134,759
-29.6%
0.02%
-42.9%
Q1 2021$18,621,000
+11.0%
191,506
+28.0%
0.03%0.0%
Q4 2020$16,772,000
+3254.4%
149,558
+2676.3%
0.03%
+2700.0%
Q3 2020$500,000
+38.1%
5,387
+16.1%
0.00%0.0%
Q2 2020$362,000
+39.8%
4,641
+4.8%
0.00%0.0%
Q1 2020$259,000
-28.5%
4,428
-2.0%
0.00%0.0%
Q4 2019$362,000
+10.0%
4,518
+0.9%
0.00%0.0%
Q3 2019$329,000
-81.7%
4,479
-76.5%
0.00%
-66.7%
Q2 2019$1,801,000
+159.5%
19,096
+120.1%
0.00%
+200.0%
Q1 2019$694,000
+199.1%
8,675
+100.9%
0.00%
Q4 2018$232,000
-31.6%
4,317
-0.6%
0.00%
Q3 2018$339,000
+17.7%
4,341
-4.2%
0.00%
Q2 2018$288,000
-33.5%
4,531
-4.1%
0.00%
-100.0%
Q1 2018$433,000
+25.5%
4,727
+3.3%
0.00%
Q4 2017$345,000
-0.9%
4,574
-8.4%
0.00%
Q3 2017$348,000
-90.8%
4,994
-93.3%
0.00%
-100.0%
Q2 2017$3,770,000
+444.8%
74,404
+330.0%
0.01%
+500.0%
Q1 2017$692,000
+51.1%
17,304
+6.0%
0.00%0.0%
Q4 2016$458,00016,3200.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2018
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders